38.77  1.63 (4.39%)		09-18 16:00
Open: 37.08 High: 40.74 Volume: 328,165		Pre. Close: 37.14 Low: 36.69 Market Cap: 1,044(M)

Short term
Mid term
Targets	6-month :	47.58	1-year :	55.57
Resists	First :	40.74	Second :	47.58
Pivot price	34.29
Supports	First :	33.39	Second :	28.86
MAs	MA(5) :	37.93	MA(20) :	34.48
	MA(100) :	28.38	MA(250) :	14.28
MACD	MACD :	1.4	Signal :	0.8
%K %D	K(14,3) :	84.4	D(3) :	87.1
RSI	RSI(14): 65.1
52-week	High :	40.74	Low :	1.15

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ WGS ] has closed below upper band by 11.1%. Bollinger Bands are 36.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	40.76 - 41.01	41.01 - 41.24
Low:	36.16 - 36.42	36.42 - 36.68
Close:	38.34 - 38.75	38.75 - 39.15

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

Fri, 13 Sep 2024
GeneDx (NASDAQ:WGS) Reaches New 12-Month High at $38.76 - MarketBeat

Thu, 12 Sep 2024
GeneDx (NASDAQ:WGS) Stock Price Up 5.7% - MarketBeat

Mon, 19 Aug 2024
GeneDx Holdings: Profits On The Horizon For AI Driven Health Platform (NASDAQ:WGS) - Seeking Alpha

Tue, 30 Jul 2024
GeneDx Holdings Corp. (WGS) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Sat, 27 Jul 2024
Market Participants Recognise GeneDx Holdings Corp.'s (NASDAQ:WGS) Revenues Pushing Shares 28% Higher - Simply Wall St

Fri, 19 Jul 2024
Opko Health sells $823k of GeneDx holdings shares - Investing.com

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Shares Out	27 (M)
Shares Float	18 (M)
Held by Insiders	26.6 (%)
Held by Institutions	62.1 (%)
Shares Short	2,190 (K)
Shares Short P.Month	1,900 (K)

EPS	-4.39
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	7.21
Profit Margin	-48.3 %
Operating Margin	-15 %
Return on Assets (ttm)	-12.2 %
Return on Equity (ttm)	-48 %
Qtrly Rev. Growth	44.7 %
Gross Profit (p.s.)	0
Sales Per Share	9.04
EBITDA (p.s.)	-2.45
Qtrly Earnings Growth	0 %
Operating Cash Flow	-92 (M)
Levered Free Cash Flow	-48 (M)

PE Ratio	-8.86
PEG Ratio	0
Price to Book value	5.37
Price to Sales	4.28
Price to Cash Flow	-11.36

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.